Literature DB >> 702054

Abelson virus-induced lymphomagenesis in mice.

R Risser, M Potter, W P Rowe.   

Abstract

The salient facts which have emerged from our study of Abelson virus (MuLV-A)lymphomagenesis in mice are that lymphoma induction is (a) age dependent, (b) virus dose dependent, and (c) under the control of host genes unrelated to other genes known to control murine leukemia (e.g., Fv-1 on Fv-2). Of 16 strains tested, only BALB/c and some of its derivative strains showed high sensitivity. Studies from CXB recombinant inbred strains and hybrids between them are interpreted to indicate that BALB/c carries dominant sensitivity alleles at two loci, tentatively designated Av-1 and Av-2, which conferon these mice partial susceptibility to MuLV-A lymphoma induction. In addition, H-2 may play a minor role in determining the susceptibility of mice to MuLV-A, its effect being seen only in mice homozygous for resistance at both Av-1 and Av-2. Virologic studies indicate that the resistance of adult B6 mice is not related to restriction on the helper virus replication, but is specific for the defective transforming virus genome.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702054      PMCID: PMC2185010          DOI: 10.1084/jem.148.3.714

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines.

Authors:  E Premkumar; M Potter; P A Singer; M D Sklar
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

3.  Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice.

Authors:  M Potter; M D Sklar; W P Rowe
Journal:  Science       Date:  1973-11-09       Impact factor: 47.728

4.  Pathogenesis of Abelson-virus-induced murine leukemia.

Authors:  R Siegler; S Zajdel
Journal:  J Natl Cancer Inst       Date:  1972-01       Impact factor: 13.506

5.  Lymphosarcoma: virus-induced thymic-independent disease in mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Major urinary protein and immunoglobulin allotypes of recombinant inbred mouse strains.

Authors:  M Potter; J S Finlayson; D W Bailey; E B Mushinski; B L Reamer; J L Walters
Journal:  Genet Res       Date:  1973-12       Impact factor: 1.588

8.  Initiation of oncogenic transformation of mouse lymphocytes in vitro by Abelson leukemia virus.

Authors:  M D Sklar; B J White; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus.

Authors:  T Pincus; W P Rowe; F Lilly
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

10.  A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses.

Authors:  T Pincus; J W Hartley; W P Rowe
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  29 in total

1.  Characterization of mouse cellular deoxyribonucleic acid homologous to Abelson murine leukemia virus-specific sequences.

Authors:  B Dale; B Ozanne
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.

Authors:  T G Lugo; O N Witte
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.

Authors:  Erica Marchlik; Richard Kalman; Naomi Rosenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Phosphorylation of the Abelson murine leukemia virus transforming protein.

Authors:  O N Witte; A Ponticelli; A Gifford; D Baltimore; N Rosenberg; J Elder
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

5.  Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.

Authors:  N E Rosenberg; D R Clark; O N Witte
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

6.  Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface.

Authors:  O N Witte; N Rosenberg; D Baltimore
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

7.  Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus.

Authors:  P L Green; D A Kaehler; R Risser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Rapid thymomas induced by Abelson murine leukemia virus.

Authors:  W D Cook
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.

Authors:  R Risser
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells.

Authors:  D J Grunwald; B Dale; J Dudley; W Lamph; B Sugden; B Ozanne; R Risser
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.